ANI Pharmaceuticals
ANIP
#5157
Rank
HK$9.51 B
Marketcap
HK$452.54
Share price
1.65%
Change (1 day)
-7.55%
Change (1 year)

Earnings for ANI Pharmaceuticals (ANIP)

Earnings in 2024 (TTM): HK$0.27 Billion

According to ANI Pharmaceuticals's latest financial reports the company's current earnings are HK$0.53 Billion. In 2023 the company made an earning of HK$0.15 Billion, an increase over its 2022 earnings that were of -HK$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ANI Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$0.27 B79.87%
2023 HK$0.15 B-131.71%
2022 -HK$0.49 Billion11.79%
2021 -HK$0.44 Billion115.92%
2020 -HK$0.21 Billion-922.36%
2019 HK$24.55 M-84.26%
2018 HK$0.15 B22.64%
2017 HK$0.12 B88.4%
2016 HK$67.48 M-60.07%
2015 HK$0.16 B12.15%
2014 HK$0.15 B-899.29%
2013 -HK$18.86 Million-91.27%
2012 -HK$0.22 Billion-46.02%
2011 -HK$0.41 Billion17.96%
2010 -HK$0.34 Billion18%
2009 -HK$0.29 Billion103.96%
2008 -HK$0.15 Billion128.68%
2007 -HK$61.62 Million-330.34%
2006 HK$26.75 M-136.98%
2005 -HK$72.35 Million-24.17%
2004 -HK$95.4 Million102.51%
2003 -HK$47.11 Million58.68%
2002 -HK$29.69 Million39.58%
2001 -HK$21.27 Million-24.1%
2000 -HK$28.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$2.31 B 737.52%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-HK$46.88 Million-116.97%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.43 B 2,229.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-HK$9.43 Billion-3,513.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.55 Billion-658.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.27 Billion-559.90%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.73 B 3,426.16%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$84.76 B 30,596.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$9.45 B 3,325.62%๐Ÿ‡ฌ๐Ÿ‡ง UK